Governance AbbVie Inc.

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - NYSE Other stock markets 04:02:28 2026-07-17 pm EDT			5-day change	1st Jan Change
254.49 ^USD	+0.04%		+2.58%	+11.38%

Jul. 17	European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus	MT
Jul. 17	AbbVie's Allergan Aesthetics Says Boey Wrinkle Treatment Wins EU Approval	MT

Executive Committee: AbbVie Inc.

Manager

Positions heldSince

Robert Michael

55 year

Chief Executive Officer

2024-06-30

Perry Siatis

51 year

General Counsel	2022-10-16
Corporate Secretary	2022-10-16

Demetris Crum

45 year

Human Resources Officer

2017-07-31

David Purdue

48 year

Comptroller/Controller/Auditor

2025-02-28

Latif Akintade

Chief Tech/Sci/R&D Officer

2023-05-31

Roopal Thakkar

54 year

Chief Tech/Sci/R&D Officer

2002-12-31

Azita Saleki-Gerhardt

62 year

Chief Operating Officer

2023-06-30

Scott Reents

59 year

Director of Finance/CFO

2022-06-22

Liz Shea

Investor Relations Contact

2012-12-31

Linda Ray

Chief Tech/Sci/R&D Officer

2024-02-29

Composition of the Board of Directors: AbbVie Inc.

Director

CommitteesSince

Robert Michael

55 year

Executive Committee Chair

2025-06-30

Roxanne Austin

65 year

Audit Committee
Executive Committee	2015-04-20
Compensation Committee
Governance Committee
Nominating Committee
Audit Committee Chair	2021-05-12
Finance Committee	2021-05-12
Governance Committee Chair	2025-11-30
Nominating Committee Chair	2025-11-30

Ed Rapp

69 year

Audit Committee	2012-12-31
Governance Committee
Nominating Committee
Compensation Committee	2021-08-19
Audit Committee Chair	2021-08-19

Thomas Freyman

71 year

Executive Committee	2020-05-07
Compensation Committee	2020-05-07
Governance Committee Chair
Nominating Committee Chair

Brett Hart

57 year

Executive Committee	2015-12-31
Governance Committee	2015-12-31
Nominating Committee	2015-12-31
Compensation Committee Chair

Jennifer Davis

54 year

Audit Committee	2023-10-10
Compensation Committee	2023-10-10
Governance Committee	2023-10-10
Nominating Committee	2023-10-10

Melody Meyer

68 year

Audit Committee	2016-12-31
Executive Committee	2016-12-31
Compensation Committee	2026-07-12

Frederick Waddell

72 year

Executive Committee
Compensation Committee
Audit Committee Chair

Thomas Falk

67 year

Governance Committee Chair	2024-05-01
Nominating Committee Chair	2024-05-01
Audit Committee	2025-05-08

Rebecca Roberts

73 year

Governance Committee
Nominating Committee

William Burnside

74 year

Executive Committee
Audit Committee	2012-12-31

Susan Quaggin

62 year

Governance Committee	2023-10-10
Nominating Committee	2023-10-10

Latest Appointments: AbbVie Inc.

May. 04	Kyverna Therapeutics, Inc. Appoints Nadia Dac as Chief Commercial Officer, Effective May 4, 2026	CI
May. 04	Tenax Therapeutics, Inc. Appoints Timothy Healey as Chief Commercial Officer, Effective May 4, 2026	CI
Apr. 16	Helus Pharma Appoints Dr. Ken Kramer as Senior Vice President, Medical Affairs, Effective April 16, 2026	CI
Mar. 23	ABIVAX Société Anonyme Announces Board and Management Changes	CI
Mar. 09	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
Feb. 24	N4 Pharma plc Announces CEO Changes	CI
Feb. 23	IDEAYA Biosciences, Inc. Announces Appointment of Dr. Theodora Ross, M.D., Ph.D., as Chief Development Officer	CI

More news

Former Officers and Directors: AbbVie Inc.

Insider

Positions held

SinceUntil

Robert Alpern

Director/Board Member	2012-12-31	2026-05-07
Independent Dir/Board Member	2012-12-31	2026-05-07

Glenn Tilton

Director/Board Member	2012-12-31	2025-06-30
Independent Dir/Board Member	2012-12-31	2025-06-30

Richard Gonzalez

Chief Executive Officer	2012-12-31	2024-06-30
Chairman	2012-12-31	2025-06-30

Tim Richmond

Human Resources Officer

2012-12-31

2025-06-29

Kevin Buckbee

Comptroller/Controller/Auditor

2023-02-28

2025-02-28

Julia Carroll Strom

Corporate Officer/Principal

2020-05-07

2025-01-31

Thomas Hudson

Chief Tech/Sci/R&D Officer	2019-06-30	2024-07-09
Corporate Officer/Principal	2015-12-31	2019-06-30

Jane Woo

Public Communications Contact

2021-03-31

2024-03-31

Katherine Rielly-Gauvin

Corporate Officer/Principal

2012-12-31

2023-06-30

Brian Durkin

Comptroller/Controller/Auditor	2015-12-31	2023-02-28
Corporate Officer/Principal	2023-02-28	2023-06-29

Frank Benenati

Public Communications Contact

2021-03-31

2023-03-31

Henry Gosebruch

Corporate Officer/Principal

2015-11-30

2023-01-31

Chris Boone

Corporate Officer/Principal

2023-01-01

Mohamed Zaki

Corporate Officer/Principal

2018-08-31

2022-11-30

Michael Severino

Chief Tech/Sci/R&D Officer	2014-05-31	2018-12-16
President	2018-12-16	2022-05-30

Edward Liddy

Director/Board Member	2012-12-31	2022-05-10
Independent Dir/Board Member	2012-12-31	2022-05-10

Kate C. Liebelt

Corporate Officer/Principal

2020-05-31

2022-04-29

Todd D. Bosse

Investor Relations Contact

2021-11-30

Nataskia Lampe

Corporate Officer/Principal

2012-02-29

2021-07-31

Carlos Alban

Director/Board Member	2018-12-16	2021-02-28
Corporate Officer/Principal	2012-12-31	2021-02-28

Jose-Carlos Gutiérrez-Ramos

Corporate Officer/Principal

2020-01-31

2020-12-31

Karen Hale

Compliance Officer

2020-12-31

Adelle Infante

Public Communications Contact

2020-11-30

Janet Hammond

Corporate Officer/Principal

2016-10-31

2020-07-31

Ronald O. Robison

General Counsel	2013-01-13	-
Corporate Officer/Principal	-	2020-03-31

Vusi Moyo

Public Communications Contact

2020-03-31

Myra Rosario Herrle

Corporate Officer/Principal

2014-07-31

2020-02-29

Frank A. Jaeger

Sales & Marketing

2013-12-31

2019-07-31

Nadia Dac

Corporate Officer/Principal

2014-11-30

2019-02-28

Scott Brun

Corporate Officer/Principal

2019-02-28

John Westwater

Director/Board Member

2018-03-31

2018-12-30

Jim Sullivan

Private Equity Investor

2012-12-31

2018-11-30

Graig Suvannavejh

Corporate Officer/Principal

2017-02-28

2018-06-30

Elizabeth Thompson

Chief Tech/Sci/R&D Officer

2015-08-31

2018-04-30

Gary Gordon

Corporate Officer/Principal

2012-12-31

2018-03-31

Paul Schwichtenberg

Corporate Officer/Principal

2013-09-30

2018-03-31

Mark Stenhouse

Corporate Officer/Principal

2016-09-30

2018-02-28

Sujay Kango

Corporate Officer/Principal

2016-12-31

2018-01-31

Shao Lee Lin

Corporate Officer/Principal

2015-03-31

2017-11-30

Thomas A. Hurwich

Comptroller/Controller/Auditor

2017-02-27

Sharon Curran

Corporate Officer/Principal

2011-12-31

2016-12-31

Francisco Velasco

Corporate Officer/Principal

2009-05-31

2016-05-31

Roy S. Roberts

Director/Board Member	2012-12-31	2016-05-05
Independent Dir/Board Member	2012-12-31	2016-05-05

Rita Jain

Corporate Officer/Principal

2012-12-31

2015-12-31

Renee Tannenbaum

Corporate Officer/Principal

2012-09-30

2015-12-31

Maria Rivas

Chief Tech/Sci/R&D Officer

2012-07-31

2015-11-30

Peter Heerma

Corporate Officer/Principal

2012-11-30

2015-10-31

David H. Donabedian

Corporate Officer/Principal

2015-07-31

Paul Wierbicki

General Counsel

2014-02-28

2015-04-30

Jennifer Smoter

Public Communications Contact

2012-07-31

2015-02-28

Barry Regan

Chief Operating Officer	2012-12-31	2015-02-28
Corporate Officer/Principal	-	-

Steven N. Gersten

Compliance Officer

2014-12-31

Alysa Spittle

Public Communications Contact

2012-12-31

2014-12-31

Gary Winer

Corporate Officer/Principal

2014-03-31

2014-12-31

Donald Frail

Corporate Officer/Principal

2013-12-31

John Leonard

Chief Tech/Sci/R&D Officer

2012-12-31

2013-12-31

Lily Chang

Private Equity Analyst

2012-12-31

2013-12-31

Lars Kielhorn

Corporate Officer/Principal

2010-12-31

2013-12-31

Jose Rivera

Compliance Officer

2012-12-31

2013-08-31

George Avgerinos

Corporate Officer/Principal

2008-06-30

2013-06-30

Laura Schumacher

General Counsel	2012-12-31	-
Corporate Secretary	2014-02-09	2022-10-16

Greg W. Linder

Director/Board Member

2012-12-30

Sharon Greenlees

Investor Relations Contact	2015-12-31	2017-12-31
Corporate Officer/Principal	2017-12-31	-

Li Malmberg

Corporate Officer/Principal

Glenn S. Warner

Corporate Officer/Principal

David Laskow-Pooley

Director/Board Member

Ann Tomlin

Human Resources Officer

Christopher Kurtz

Corporate Officer/Principal

William Chase

Chief Administrative Officer	2018-10-18	-
Director of Finance/CFO	-	2018-10-18

Douglas Feltner

Corporate Officer/Principal

Björn Cochlovius

Corporate Officer/Principal

Larry Peepo

Investor Relations Contact

Gregory Miley

Public Communications Contact	-	-
General Counsel	-	-

Star Seyedkazemi

Corporate Officer/Principal

Kimberly Davis-Wells

Corporate Officer/Principal

Saeed Motahari

Corporate Officer/Principal

Youssef Bennani

Corporate Officer/Principal

Gentry Lassiter

Public Communications Contact

Jordan Dubow

Corporate Officer/Principal

James P. Sullivan

Corporate Officer/Principal

Denelle Waynick

General Counsel

Derrell Porter

Sales & Marketing

Barbara McGovern

Corporate Officer/Principal

Paulo Vega

Corporate Officer/Principal

Karl G. Trass

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	19
Female	7

Of which Executive Committee

Male	8
Female	2

Of which Directors

Male	8
Female	4

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).

Employees

57,000

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company